Screening for regenerative therapy responders in heart failure

Authors are supported by the National Institutes of Health (R01 HL134664), Regenerative Medicine Minnesota, Marriott Family Foundation, Van Cleve Cardiac Regenerative Medicine Program, Michael S and Mary Sue Shannon Family, Center for Regenerative Medicine, Center for Biomedical Discovery and Medical Scientist Training Program at Mayo Clinic. A Terzic holds the Marriott Family Professorship in Cardiovascular Diseases Research, and is Michael S and Mary Sue Shannon Director of the Mayo Clinic Center for Regenerative Medicine. S Yamada, A Behfar and A Terzic are inventors on regenerative sciences related intellectual property disclosed to Mayo Clinic. Previously, Mayo Clinic has administered research grants from Celyad. Mayo Clinic, A Behfar and A Terzic have interests in Rion LLC. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

留言 (0)

沒有登入
gif